Search

Your search keyword '"Sanmartín, O"' showing total 115 results
Start Over Author "Sanmartín, O" Journal actas dermo-sifiliograficas
115 results on '"Sanmartín, O"'

2. [Translated article] Lymphovascular Invasion and High Mitotic Count Are Associated With Increased Risk of Recurrence in Pleomorphic Dermal Sarcoma

Author

Pons Benavent, M., primary, Ríos-Viñuela, E., additional, Nagore, E., additional, Monteagudo, C., additional, Aguerralde, M., additional, Mata Cano, D., additional, Llombart, B., additional, Serra-Guillén, C., additional, Pinazo Canales, I., additional, Requena, C., additional, and Sanmartín, O., additional

Published
2023
Full Text
View/download PDF

3. La Presencia De Infiltración Linfovascular Y De Un Alto Número De Mitosis Se Asocian A Un Mayor Riesgo De Recidiva En Sarcoma Pleomórfico Dérmico

Author

Pons Benavent, M., primary, Ríos-Viñuela, E., additional, Nagore, E., additional, Monteagudo, C., additional, Aguerralde, M., additional, Mata Cano, D., additional, Llombart, B., additional, Serra-Guillén, C., additional, Pinazo Canales, I., additional, Requena, C., additional, and Sanmartín, O., additional

Published
2023
Full Text
View/download PDF

8. Granulomas en dermatopatología: principales entidades. Parte II

Author

Aróstegui Aguilar, J., primary, Diago, A., additional, Carrillo Gijón, R., additional, Fernández Figueras, M., additional, Fraga, J., additional, García Herrera, A., additional, Garrido, M., additional, Idoate Gastearena, M.A., additional, Christian Laga, A., additional, Llamas-Velasco, M., additional, Martínez Campayo, N., additional, Monteagudo, C., additional, Onrubia, J., additional, Pérez Muñoz, N., additional, Ríos-Martín, J.J., additional, Ríos-Viñuela, E., additional, Rodríguez Peralto, J.L., additional, Rozas Muñoz, E., additional, Sanmartín, O., additional, Santonja, C., additional, Santos-Briz, A., additional, Saus, C., additional, Suárez Peñaranda, J.M., additional, Velasco Benito, V., additional, Beato Merino, M.J., additional, and Fernandez-Flores, A., additional

Published
2021
Full Text
View/download PDF

10. Dermatopatología de la oclusión intraluminal vascular: parte II (coagulopatías, émbolos y miscelánea)

Author

Beato Merino, M.J., primary, Diago, A., additional, Fernandez-Flores, A., additional, Fraga, J., additional, García Herrera, A., additional, Garrido, M., additional, Idoate Gastearena, M.A., additional, Llamas-Velasco, M., additional, Monteagudo, C., additional, Onrubia, J., additional, Pérez-González, Y.C., additional, Pérez Muñoz, N., additional, Ríos-Martín, J.J., additional, Ríos-Viñuela, E., additional, Rodríguez Peralto, J.L., additional, Rozas Muñoz, E., additional, Sanmartín, O., additional, Santonja, C., additional, Santos-Briz, A., additional, Saus, C., additional, Suárez Peñaranda, J.M., additional, and Velasco Benito, V., additional

Published
2021
Full Text
View/download PDF

11. Dermatopatología de la oclusión intraluminal vascular: parte I (trombos)

Author

Beato Merino, M.J., primary, Diago, A., additional, Fernández-Flores, Á., additional, Fraga, J., additional, García Herrera, A., additional, Garrido, M., additional, Idoate Gastearena, M.Á., additional, Llamas-Velasco, M., additional, Monteagudo, C., additional, Onrubia, J., additional, Pérez-González, Y.C., additional, Pérez Muñoz, N., additional, Ríos-Martín, J.J., additional, Ríos-Viñuela, E., additional, Rodríguez Peralto, J.L., additional, Rozas Muñoz, E., additional, Sanmartín, O., additional, Santonja, C., additional, Santos-Briz, Á., additional, Saus, C., additional, Suárez Peñaranda, J.M., additional, and Velasco Benito, V., additional

Published
2021
Full Text
View/download PDF

12. Estimación del efecto en el tamaño y la supervivencia de los tumores cutáneos debido al confinamiento por COVID-19: modelo basado en un crecimiento exponencial

Author

Tejera-Vaquerizo, A., primary, Cañueto, J., additional, Toll, A., additional, Santos-Juanes, J., additional, Jaka, A., additional, Ferrandiz-Pulido, C., additional, Sanmartín, O., additional, Ribero, S., additional, Moreno-Ramírez, D., additional, Almazán, F., additional, Fuente, M.J., additional, Podlipnik, S., additional, and Nagore, E., additional

Published
2020
Full Text
View/download PDF

13. Manejo clínico de los eventos adversos cutáneos en pacientes tratados con quimioterapia: consenso nacional de la Academia Española de Dermatología y Venereología y de la Sociedad Española de Oncología Médica

Author

Sanmartín, O., primary, Beato, C., additional, Suh-Oh, H. Jin, additional, Aragón, I., additional, España, A., additional, Majem, M., additional, Segura, S., additional, Gúrpide, A., additional, Botella, R., additional, and Grávalos, C., additional

Published
2019
Full Text
View/download PDF

18. Granulomas in Dermatopathology: Principal Diagnoses - Part 1

Author

Aróstegui Aguilar, J., Diago, A., Carrillo Gijón, R., Fernández Figueras, M., Fraga, J., García Herrera, A., Garrido, M., Idoate Gastearena, M.A., Christian Laga, A., Llamas-Velasco, M., Martínez Campayo, N., Monteagudo, C., Onrubia, J., Pérez Muñoz, N., Ríos-Martín, J.J., Ríos-Viñuela, E., Rodríguez Peralto, J.L., Rozas Muñoz, E., Sanmartín, O., Santonja, C., Santos-Briz, A., Saus, C., Suárez Peñaranda, J.M., Velasco Benito, V., Beato Merino, M.J., and Fernandez-Flores, A.

Abstract

This series of 2 articles on dermatopathologic diagnoses reviews conditions in which granulomas form. Part 1 clarifies concepts, discusses the presentation of different types of granulomas and giant cells, and considers a large variety of noninfectious diseases. Some granulomatous diseases have a metabolic origin, as in necrobiosis lipoidica. Others, such as granulomatous mycosis fungoides, are related to lymphomas. Still others, such as rosacea, are so common that dermatologists see them nearly daily in clinical practice.

Published
2021
Full Text
View/download PDF

22. Dermatopatología de la oclusión intraluminal vascular: parteII (coagulopatías, émbolos y miscelánea)

Author

Beato Merino, M.J., Diago, A., Fernandez-Flores, A., Fraga, J., García Herrera, A., Garrido, M., Idoate Gastearena, M.A., Llamas-Velasco, M., Monteagudo, C., Onrubia, J., Pérez-González, Y.C., Pérez Muñoz, N., Ríos-Martín, J.J., Ríos-Viñuela, E., Rodríguez Peralto, J.L., Rozas Muñoz, E., Sanmartín, O., Santonja, C., Santos-Briz, A., Saus, C., Suárez Peñaranda, J.M., and Velasco Benito, V.

Published
2021
Full Text
View/download PDF

23. Clinical and Histopathologic Characteristics of the Main Causes of Vascular Occusion — Part I: Thrombi

Author

Beato Merino, M.J., Diago, A., Fernandez-Flores, A., Fraga, J., García Herrera, A., Garrido, M., Idoate Gastearena, M.A., Llamas-Velasco, M., Monteagudo, C., Onrubia, J., Pérez-González, Y.C., Pérez Muñoz, N., Ríos-Martín, J.J., Ríos-Viñuela, E., Rodríguez Peralto, J.L., Rozas Muñoz, E., Sanmartín, O., Santonja, C., Santos-Briz, A., Saus, C., Suárez Peñaranda, J.M., and Velasco Benito, V.

Abstract

Vascular occlusion has multiple, diverse clinical manifestations, some of which can have grave consequences for patients. The causes of vascular occlusion are also highly variable, ranging from thrombi triggered by the uncontrolled activation of coagulation mechanisms, on the one hand, to endothelial dysfunction or occlusion by material extrinsic to the coagulation system on the other. In a 2-part review, we look at the main causes of vascular occlusion and the key clinical and histopathologic findings. In this first part, we focus on vascular occlusion involving thrombi.

Published
2021
Full Text
View/download PDF

27. Estudio longitudinal de los diferentes patrones de progresión en el carcinoma cutáneo de células escamosas de alto riesgo

Author

Vaquerizo, A Tejera, Cañueto, J, Tomás, Á Gómez, Juanes, J Santos, Ribero, S, Avallone, G, Jaka, A, Pulido, C Ferrandiz, Toll, A, and Sanmartín, O

Abstract

Antecedentes y objetivo. El carcinoma cutáneo de células escamosas (CEC) es la segunda causa de fallecimientos por cáncer de piel en Europa. Existen pocos estudios que hayan analizado las distintas vías de progresión de este tumor en su historia natural. El objetivo principal del presente estudio ha sido analizar las diferentes vías metastásicas, así como de progresión y su aparición temporal en la evolución del CEC.

Published
2024
Full Text
View/download PDF

29. Interobserver Variability in the Histopathological Evaluation of Melanoma: Analysis of 60 Cases

Author

Sanz-Motilva, V., Martorell, A., Manrique-Silva, E., Terradez-Mas, L., Requena, C., Traves, V., Sanmartín, O., Rodríguez-Peralto, J.L., and Nagore, E.

Abstract

Since the field of dermatopathology is not an exact science, it is subject to personal subjectivity, which sometimes causes disagreements on the diagnosis and assessment of some histological features. In the case of melanoma, some variables such as regression are associated with low interobserver agreement. On the contrary, other variables such as the measurement of Breslow thickness show high reproducibility.

Published
2024
Full Text
View/download PDF

31. Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology

Author

Sanmartín, O., Beato, C., Suh-Oh, H. Jin, Aragón, I., España, A., Majem, M., Segura, S., Gúrpide, A., Botella, R., and Grávalos, C.

Abstract

Although the arrival of new chemotherapy drugs and combinations has brought progress in terms of cancer patient survival, they entail many adverse effects that can compromise treatment, and hence prognosis, of the disease. Cytostatic agents can cause dermatological toxicity, among other side effects. The most familiar adverse effect of chemotherapy is alopecia. Although not serious, this changes the outward appearance of cancer patients. Other adverse effects include hypersensitivity and photosensitivity reactions, hand-foot syndrome, epidermal necrolysis, recall reactions, scleroderma-like reactions, Raynaud's phenomenon, eccrine squamous syringometaplasia, neutrophilic eccrine hidradenitis, nail abnormalities, pigmentation changes and extravasation injuries. Onset of these adverse effects often causes dose reduction and/or delayed treatment, which can affect patient survival and quality of life. It is therefore important to prevent their occurrence and treat them promptly, which requires cooperation between medical oncologists and dermatologists. This article reviews chemotherapy-associated dermatological toxicity, along with its diagnosis and therapeutic management.

Published
2019
Full Text
View/download PDF

32. Postirradiation Morphea in Patients With Breast Cancer: Possible Association With Other Autoimmune Diseases

Author

Diago, A., Llombart, B., Requena, C., Sanmartín, O., and Guillén, C.

Abstract

Postirradiation morphea is an uncommon entity that has been mostly described in women with breast cancer. The increasing use of radiotherapy to treat breast cancer and the clinical similarities between morphea and other conditions, such as radiodermatitis, postirradiation fibrosis, and tumor recurrence, highlights the need for dermatologists to be familiar with this entity. We present a series of 6 women with a mean age of 64.2 years and a mean latency of 9.5 years between radiotherapy for breast cancer and onset of morphea. Four of the patients had a history of autoimmune disease: rheumatoid arthritis, Sjögren syndrome, vitiligo, and Crohn disease. No specific risk factors for postirradiation morphea have been identified to date, although it would appear that a history of autoimmune disease could be associated with an increased risk of morphea in patients treated with radiation therapy.

Published
2019
Full Text
View/download PDF

34. Kaposi Sarcoma and Cutaneous Angiosarcoma: Guidelines for Diagnosis and Treatment

Author

Requena, C., Alsina, M., Morgado-Carrasco, D., Cruz, J., Sanmartín, O., Serra-Guillén, C., and Llombart, B.

Abstract

Kaposi sarcoma is a vascular sarcoma with 4 clinical variants: classic Kaposi sarcoma, which mainly affect the extremities of elderly patients and follows a chronic, generally indolent course; African Kaposi sarcoma; immunosuppression-associated Kaposi sarcoma; and AIDS-associated Kaposi sarcoma. Type8 human herpesvirus is the etiologic agent in all 4variants. Cutaneous angiosarcoma is a cutaneous neoplasm with a very poor prognosis. It carries a high probability of local relapse and has a 10% to 15% survival rate at 5years. There are 3 main variants of cutaneous angiosarcoma: idiopathic angiosarcoma of the face and scalp; Stewart-Treves syndrome; and postradiation angiosarcoma. The only potentially curative treatment is surgery with or without radiotherapy. However, its indistinct borders and multicentric nature mean that treatment is often palliative with chemotherapy, radiotherapy, or both.

Published
2018
Full Text
View/download PDF

35. Guidelines for Diagnosis and Treatment of Cutaneous Sarcomas: Dermatofibrosarcoma Protuberans

Author

Llombart, B., Serra, C., Requena, C., Alsina, M., Morgado-Carrasco, D., Través, V., and Sanmartín, O.

Abstract

Sarcomas comprise a broad group of tumors, many of whose biological behavior and aggressiveness differ from one type to another. The therapeutic approach is generally multidisciplinary and often complex. Developments in surgical and oncological dermatology during the last few decades have positioned dermatologists as specialists in the diagnosis and treatment of skin cancer. The aim of this article is to review the main soft tissue sarcomas that typically affect the skin. Dermatofibrosarcoma protuberans is a low-grade malignant sarcoma. It exhibits slow-growth, is locally invasive, and has low metastatic potential (<3%). Mohs micrographic surgery is the treatment of choice. The COL1A1-PDGFBtranslocation should be analyzed in cases of unclear diagnosis and when it is necessary to identify candidates for tyrosine kinase inhibitors. Imatinib is indicated for the treatment of locally advanced and metastatic dermatofibrosarcoma protuberans.

Published
2018
Full Text
View/download PDF

37. Experience With Vismodegib in the Treatment of Advanced Basal Cell Carcinoma at a Cancer Center

Author

Bernia, E., Llombart, B., Serra-Guillén, C., Bancalari, B., Nagore, E., Requena, C., Calomarde, L., Diago, A., Lavernia, J., Traves, V., Guillén, C., and Sanmartín, O.

Abstract

Vismodegib is the first selective Hedgehog inhibitor approved for the treatment of locally advanced and metastatic basal cell carcinoma (BCC). In this article, we describe our experience with the use of this drug to treat advanced and/or multiple BCCs at a cancer center over 5 years.

Published
2018
Full Text
View/download PDF

38. A 12-Day Course of Imiquimod 5% for the Treatment of Actinic Keratosis: Effectiveness and Local Reactions

Author

Serra-Guillén, C., Nagore, E., Llombart, B., Sanmartín, O., Requena, C., Calomarde, L., and Guillén, C.

Abstract

Imiquimod is an excellent option for patients with actinic keratosis, although its use may be limited by the long course of treatment required (4 weeks) and the likelihood of local skin reactions. The objectives of the present study were to demonstrate the effectiveness of a 12-day course of imiquimod 5% for the treatment of actinic keratosis and to examine the association between treatment effectiveness and severity of local reactions.

Published
2018
Full Text
View/download PDF

44. Cutaneous Angiosarcoma: Clinical and Pathology Study of 16 Cases

Author

Requena, C., Sendra, E., Llombart, B., Sanmartín, O., Guillén, C., Lavernia, J., Traves, V., and Cruz, J.

Abstract

Primary cutaneous angiosarcoma is one of the most aggressive skin tumors and carries a very poor prognosis. Its initially indolent clinical presentation explains the frequently late diagnosis that, together with its typically multifocal pattern and poor delimitation, often makes surgery difficult. The low incidence of primary cutaneous angiosarcoma means that few large single-center series have been published. We review the clinical and pathologic characteristics of cutaneous angiosarcomas treated in our hospital, looking for prognostic factors and for possible diagnostic traits that could facilitate early diagnosis.

Published
2017
Full Text
View/download PDF

46. Ensayo clínico: la infiltración intralesional con metotrexato de forma neoadyuvante en la cirugía del queratoacantoma permite obtener mejores resultados estéticos y funcionales

Author

Martorell-Calatayud, A., primary, Requena, C., additional, Nagore, E., additional, Sanmartín, O., additional, Serra-Guillén, C., additional, Botella-Estrada, R., additional, Sanz-Motilva, V., additional, Llombart, B., additional, Alcañiz-Moscardo, A., additional, and Guillén-Barona, C., additional

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results